标签儿科产品:BPCA的努力和孤儿药的机会
Hui Wei1, Gilbert J Burckart1, Perdita Taylor-Zapata2
1Office of Clinical Pharmacology (HW, GJB, YW), Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
概括
儿童最佳药品法案 (BPCA) 倡议成功确定了孤儿药物的儿科数据. 塔费诺昆和米尔特福辛在儿科患者中显示了可比的暴露,支持它们对罕见疾病的标签.
科学领域:
- 儿科药理学 儿科药理学
- 罕见疾病药物开发 罕见疾病药物开发
- 监管科学是一种监管科学.
背景情况:
- 孤儿药物法案 (ODA) 增加了罕见病疗法,但儿童的需求仍然存在.
- "儿童最佳药品法案" (BPCA) 旨在改善儿科药物标签.
- 对于未完全标记为儿科使用的孤儿药物,仍然存在未得到满足的需求.
研究的目的:
- 探索公开可用的孤儿药物儿科数据.
- 推进对缺乏儿科标签的孤儿产品的评估.
- 为了记录NIH的BPCA在儿童用药品标签方面的努力.
主要方法:
- 记录了NIH BPCA药物标签工作.
- 分析了ODA识别的孤儿药物的公开可用的儿科数据.
- 对已发表的研究数据进行非分组分析.
主要成果:
- 确定了tafenoquine和miltefosine的儿科数据.
- 儿科患者 (2-15岁) 的tafenoquine暴露与成年人相当.
- 密尔特福辛暴露-反应分析显示,在儿科患者 (2-12岁) 中具有很高的相似性.
结论:
- 塔费诺昆片和密尔特福辛囊可以考虑进行全面的儿科标签.
- 这些发现支持BPCA扩大儿科药物适用范围的目标.
- 公共可用的数据可以帮助评估儿童群体的孤儿药物.
相关概念视频
Prescription, Nonprescription and Orphan Drugs
848
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
848
Drug Regulation
1.8K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.8K
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Drug Nomenclature
2.3K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
2.3K
Prodrugs
2.9K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.9K
Drug Discovery: Overview
8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K


